human rheumatoid arthritis tissue production of il-17a drives matrix and cartilage degradation synergy with tumour necrosis factor-α, oncostatin m and response to biologic therapies人类风湿性关节炎组织生产il-17a驱动矩阵和软骨降解协同作用与肿瘤坏死factor-α制瘤素m和应对生物疗法.pdfVIP

  • 2
  • 0
  • 约7.86万字
  • 约 12页
  • 2017-09-06 发布于上海
  • 举报

human rheumatoid arthritis tissue production of il-17a drives matrix and cartilage degradation synergy with tumour necrosis factor-α, oncostatin m and response to biologic therapies人类风湿性关节炎组织生产il-17a驱动矩阵和软骨降解协同作用与肿瘤坏死factor-α制瘤素m和应对生物疗法.pdf

human rheumatoid arthritis tissue production of il-17a drives matrix and cartilage degradation synergy with tumour necrosis factor-α, oncostatin m and response to biologic therapies人类风湿性关节炎组织生产il-17a驱动矩阵和软骨降解协同作用与肿瘤坏死factor-α制瘤素m和应对生物疗法

Available online /content/11/4/R113 Vol 11 No 4 Open Access Research article Human rheumatoid arthritis tissue production of IL-17A drives matrix and cartilage degradation: synergy with tumour necrosis factor-α, Oncostatin M and response to biologic therapies Ellen M Moran, Ronan Mullan, Jennifer McCormick, Mary Connolly, Owen Sullivan, Oliver FitzGerald, Barry Bresnihan, Douglas J Veale

您可能关注的文档

文档评论(0)

1亿VIP精品文档

相关文档